oncolysin m
mAbexperimentalADC
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Myeloid cell surface antigen CD33BINDING AGENT
CD33 binding agent
Immunotoxin.
- Myeloid cell surface antigen CD33INHIBITOR
CD33 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- Ricin A chain
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109520 ↗
Also known as
- oncolysin m